You are here

  • Home
  • Archive
  • Volume 93, Issue 2
  • Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

Article Text

Article menu
Download PDFPDF
Letter
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

https://doi.org/10.1136/bjo.2008.145714

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding: Foundation Fighting Blindness, Owings Mills, Maryland, USA; Dean’s Grant Support, University of Florida, Jacksonville, Florida, USA. Study sponsors did not participate in the study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the paper for publication.

    • Competing interests: None.

    • Ethics approval: From the local University of Florida IRB.

    • Patient consent: Obtained.